{
  "id": "1c15cd3e070f3fac",
  "title": "Why Is Ocular Therapeutix Stock Skyrocketing Monday ? - Ocular Therapeutix ( NASDAQ : OCUL ) ",
  "description": "20251208T193000Z",
  "content": "",
  "source": "benzinga.com",
  "source_url": "https://www.benzinga.com/news/fda/25/12/49264012/ocular-therapeutix-stock-skyrockets-on-faster-fda-path-for-vision-drug",
  "published_at": "20251208T193000Z",
  "fetched_at": "2025-12-09T00:22:19.510482+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.benzinga.com/news/fda/25/12/49264012/ocular-therapeutix-stock-skyrockets-on-faster-fda-path-for-vision-drug",
    "url_mobile": "",
    "title": "Why Is Ocular Therapeutix Stock Skyrocketing Monday ? - Ocular Therapeutix ( NASDAQ : OCUL ) ",
    "seendate": "20251208T193000Z",
    "socialimage": "https://cdn.benzinga.com/files/images/story/2025/12/08/Eye-eyechart-ocular.jpeg?&fit=crop",
    "domain": "benzinga.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}